Belgium· BE-AMP-SAM665934-00
Rezurock 200 mg
A belumosudil product containing belumosudil mesylate, registered in Belgium by Sanofi Winthrop Industrie. The same ATC class is registered in 12 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Belumosudil is registered in 12 of 19 countries.
Countries holding a registration under ATC L04AA48 (belumosudil), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
Belumosudil · ATC L04AA48
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Spainprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Belumosudil Mesylate
- Manufacturer
- Sanofi Winthrop Industrie
- Country
- Belgium (BE)
- ATC code
- L04AA48
- ATC class
- Belumosudil
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Belumosudil in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaREZUROCKSanofi Winthrop Industrie, Gentilly
- SpainREZUROCK 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULASanofi Winthrop Industrie
- FinlandREZUROCKSanofi Winthrop Industrie
- IrelandREZUROCK 200 mg film-coated tabletsSanofi Winthrop Industrie
- IcelandREZUROCKSanofi Winthrop Industrie
- NetherlandsREZUROCK 200 mg, filmomhulde tablettenSanofi Winthrop Industrie
- SwedenREZUROCK 200 mg Filmdragerad tablettSanofi Winthrop Industrie
- United KingdomRezurock 200mg tabletsSanofi
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Rezurock
- Liechtenstein · Rezurock
- Norway · Rezurock
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/60021899-8095-41df-bc9f-220f9bb2ff8e GET /v1/drugs/60021899-8095-41df-bc9f-220f9bb2ff8e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Rezurock 200 mg",
"name_fr": "Rezurock 200 mg",
"name_nl": "Rezurock 200 mg",
"amp_code": "SAM665934-00",
"strengths": [
"200.0000",
"200.0000"
],
"pack_count": 2,
"substances": [
"Belumosudil Mesylate",
"Belumosudil"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Belumosudil",
"authorisation_numbers": [
"EU/1/26/2015/001",
"EU/1/26/2015/002"
]
}See everything about belumosudil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.